30 Growing Dividend Stocks with Low PE Ratios

Page 12 of 27

16. AbbVie Inc. (NYSE:ABBV)

Forward P/E Ratio as of April 22: 13.99

AbbVie Inc. (NYSE:ABBV) ranks 16th on our list of the best growing dividend stocks with low P/E ratios. The American multinational pharmaceutical company currently carries $67 billion in debt, largely due to a series of acquisitions made in recent years. While the company is expected to continue increasing its dividend, the focus in the near term will likely shift toward reducing that debt. Though this level of debt isn’t seen as alarming, given the firm’s solid A- credit rating from S&P Global, it’s still a factor investors may want to keep in mind

In the fourth quarter of fiscal 2025, AbbVie Inc. (NYSE:ABBV) posted revenue of $15.1 billion, reflecting a 5.6% increase compared to the same period a year earlier and surpassing analysts’ forecasts of $14.87 billion. Although the company reported a minor GAAP net loss of $0.02 per share, its adjusted diluted earnings came in at $2.16 per share, slightly ahead of the projected $2.13. Over the full year 2024, combined sales of Skyrizi and Rinvoq climbed 51%, reaching $1.77 billion, supported by rising demand across global markets and broader adoption.

AbbVie Inc. (NYSE:ABBV) pays a quarterly dividend of $1.64 per share and has a dividend yield of 3.77%, as recorded on April 22. The company’s dividend growth streak spans 52 years, grabbing attention from income investors.

Page 12 of 27